Two OncoDaily Mentors, One Global Mission: Matti Aapro and Hesham Elghazaly Run for UICC Board
Pope Leo XIV Lung Cancer Diagnosis: Surgery, Prognosis and Survival Rates
OncoDaily Academy Introduces the First Module of its Six-part Programme on Immune Checkpoint Inhibitors
TRACE-I: Long-Term Outcomes of PSMA-Guided Salvage Surgery in Recurrent Prostate Cancer
Can Maintenance HER2 Therapy Be Stopped? Global Survey Reveals Clinical Equipoise in Long-Term Responders
Melvin L.K. Chua: Defining Where Proton Beam Therapy Benefits Nasopharyngeal Carcinoma
Miriam Mutebi: What Does Resilience Really Mean for Women Navigating Our Healthcare Systems?
Can Distant Lymph Nodes Sustain Immunotherapy After Lymph-Node Surgery?
OncoDaily GI is the dedicated GI cancer platform of OncoDaily, focused on the rapidly evolving field of gastrointestinal oncology. It covers the full spectrum of GI malignancies, including colorectal, anal canal, gastric, gastroesophageal junction (GEJ), esophageal, small bowel, pancreatic, hepatocellular, and biliary tract cancers. Through OncoDaily GI, readers can follow the latest clinical trial developments, ongoing research, FDA and EMA approvals, guideline updates, emerging therapies, advances in biomarkers and precision oncology, major conference findings, and interviews with leading experts in the field.
